Aura Biosciences (NASDAQ:AURA) Receives Buy Rating from HC Wainwright
HC Wainwright reissued their buy rating on shares of Aura Biosciences (NASDAQ:AURA – Free Report) in a research note released on Thursday morning,Benzinga reports. HC Wainwright currently has a $22.00 price target on the stock. A number of other research analysts have also recently commented on the company. Cowen reissued a “buy” rating on shares […]
More Stories
**DarioHealth Corp. Enters Into Securities Purchase Agreements for Private Placement Financing****
** On December 16, 2024, DarioHealth Corp. (NASDAQ: DRIO) finalized securities purchase agreements with accredited investors, marking an important step...
Tamarack Valley Energy (OTCMKTS:TNEYF) Shares Down 1.7% – Should You Sell?
Tamarack Valley Energy Ltd. (OTCMKTS:TNEYF – Get Free Report) shares dropped 1.7% during mid-day trading on Monday . The company...
White Gold (CVE:WGO) Stock Price Down 4.7% – What’s Next?
Shares of White Gold Corp. (CVE:WGO – Get Free Report) fell 4.7% during trading on Monday . The company traded...
Anglo Pacific Group (TSE:APY) Stock Price Down 4.2% – Here’s Why
Anglo Pacific Group plc (TSE:APY – Get Free Report)’s stock price dropped 4.2% on Monday . The company traded as...
CanniMed Therapeutics (TSE:CMED) Trading Down 5.3% – Here’s Why
CanniMed Therapeutics Inc. (TSE:CMED – Get Free Report)’s stock price fell 5.3% on Monday . The stock traded as low...
Van Elle (LON:VANL) Trading Down 2.6% – Here’s Why
Van Elle Holdings plc (LON:VANL – Get Free Report)’s stock price was down 2.6% on Monday . The company traded...